Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Protalix Rises Most in Week, Narrows Gap With U.S. Stock

Protalix BioTherapeutics Inc., a Carmiel-based biotechnology company, jumped the most in more than a week, narrowing the gap with its U.S.-traded shares.

The shares gained 6.5 percent, the most since Nov. 28, to 20.13 shekels, or the equivalent of $5.37, at 11:23 a.m. in Tel Aviv. Protalix closed at $5.39 yesterday in New York.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.